Medicine guide
FRAMYXONE
As listed in the register: FRAMYXONE, solution pour instillation auriculaire
700 000 UI + 0,100 g · solution pour instillation
- Prescription only
- Active substance
- Sulfate De Framycétine + Sulfate De Polymyxine B + Phosphate Sodique De Dexaméthasone
- Made by
- CILFA DEVELOPPEMENT
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | CILFA DEVELOPPEMENT |
|---|---|
| Active substance | Sulfate De Framycétine + Sulfate De Polymyxine B + Phosphate Sodique De Dexaméthasone |
| Strength | 700 000 UI + 0,100 g |
| Form | solution pour instillation |
| Route | auriculaire |
| Dispensing (as stated by the register) | liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure nationale |
| Name in the register | FRAMYXONE, solution pour instillation auriculaire |
| Packs | 1 flacon(s) polyéthylène basse densité (PEBD) de 10 ml avec compte-gouttes polypropylène |
| CIS | 66586731 |
| CIP13 | 3400934151446 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).